Literature DB >> 11900051

Proliferation conditions for human satellite cells. The fractional content of satellite cells.

M Gaster1, H Beck-Nielsen, H D Schrøder.   

Abstract

Primary satellite cell cultures have become an important tool as a model system for skeletal muscles. A common problem in human satellite cell culturing is fibroblast overgrowth. We combined N-CAM (Leu19) immunocytochemical staining of satellite cells (Sc) with stereological methods to estimate the fraction of Sc in culture. Evaluation of different culture conditions allowed us to find proliferation conditions preferentially for Sc: a) Sc should be cultured on surfaces coated with ECM-gel. b) Primary cell culture should be inoculated in DMEM supplemented with 10% fetal calf serum to increase cell adherence. c) Change of media to DMEM supplemented with 2% Ultroser-G and 2% FCS after 24 h.d) Before subcultivation, cells should be preplated for 30 min. The fractional content of Sc in passage four when applying this method of cultivation was 0.82 +/- 0.07 (mean +/- SE, N = 10). Our method enabled us to establish culture conditions which resulted in high Sc content despite several subcultivations. Estimation of the fractional cell content could be a useful tool for optimizing not only Sc-culturing but all cultures initially containing more cell types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11900051     DOI: 10.1034/j.1600-0463.2001.d01-139.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  25 in total

1.  Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages.

Authors:  S Machida; E E Spangenburg; F W Booth
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

2.  Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells.

Authors:  V Aas; E T Kase; R Solberg; J Jensen; A C Rustan
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

3.  Uncoupling of sarcoplasmic reticulum Ca²⁺-ATPase by N-arachidonoyl dopamine. Members of the endocannabinoid family as thermogenic drugs.

Authors:  Y A Mahmmoud; M Gaster
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.

Authors:  Tine E Thingholm; Steffen Bak; Henning Beck-Nielsen; Ole N Jensen; Michael Gaster
Journal:  Mol Cell Proteomics       Date:  2011-06-22       Impact factor: 5.911

5.  Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.

Authors:  Adiba Isa; Jan O Nehlin; Hardee J Sabir; Tom E Andersen; Michael Gaster; Moustapha Kassem; Torben Barington
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

6.  Enhanced proliferation of human skeletal muscle precursor cells derived from elderly donors cultured in estimated physiological (5%) oxygen.

Authors:  Sheree D Martin; Fiona M Collier; Mark A Kirkland; Ken Walder; Nicole Stupka
Journal:  Cytotechnology       Date:  2010-01-22       Impact factor: 2.058

7.  Isolation and Purification of Satellite Cells for Skeletal Muscle Tissue Engineering.

Authors:  Brian C Syverud; Jonah D Lee; Keith W VanDusen; Lisa M Larkin
Journal:  J Regen Med       Date:  2014

Review 8.  Design, evaluation, and application of engineered skeletal muscle.

Authors:  Mark Juhas; Jean Ye; Nenad Bursac
Journal:  Methods       Date:  2015-10-06       Impact factor: 3.608

9.  FA1 Induces Pro-Inflammatory and Anti-Adipogenic Pathways/Markers in Human Myotubes Established from Lean, Obese, and Type 2 Diabetic Subjects but Not Insulin Resistance.

Authors:  Basem M Abdallah; Henning Beck-Nielsen; Michael Gaster
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-05       Impact factor: 5.555

10.  A novel in vitro model for studying quiescence and activation of primary isolated human myoblasts.

Authors:  Jeeva Sellathurai; Sirisha Cheedipudi; Jyotsna Dhawan; Henrik Daa Schrøder
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.